Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/27159
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Markman B. | en |
dc.contributor.author | Chandrasekara S.D. | en |
dc.contributor.author | Anthony S.N. | en |
dc.contributor.author | Raghunath A. | en |
dc.date.accessioned | 2021-05-14T09:06:06Z | en |
dc.date.available | 2021-05-14T09:06:06Z | en |
dc.date.copyright | 2019 | en |
dc.date.created | 20210301 | en |
dc.date.issued | 2021-03-01 | en |
dc.identifier.citation | Asia-Pacific Journal of Clinical Oncology. Conference: 46th Annual Scientific Meeting, Urological Cancer; Age and Gender in Cancer Practice; Digital Health in Cancer. Adelaide, SA Australia. 15 (SUPPL 9) (pp 165-166), 2019. Date of Publication: November 2019. | en |
dc.identifier.issn | 1743-7563 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/27159 | en |
dc.description.abstract | Aims: Chemotherapy-induced nausea and vomiting is the most common non-haematological toxicity of chemotherapy. Our objective was to determine the optimal duration of dexamethasone treatment in preventing chemotherapy-induced nausea and vomiting. Method(s): Searches were conducted inMEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and ClinicalTrials.gov. Eligible studies were randomised controlled studies comparing a short course (1-2 days) to a long course (3 or more days) of dexamethasone in patients receiving chemotherapy. The same regimen of adjunctanti-emetics was required in both arms. Primary outcome was complete responsewith no nausea or vomiting and the secondary outcome was adverse effects. Screening and data extraction were conducted independently by two authors. A random effects model was used for both outcomes. Subgroup analysis was performed by chemotherapy emetogenicity and use of an NK1 inhibitor. Risk of bias was assessed with the Cochrane risk of bias tool. Result(s): One thousand thirty-five articles were screened to identify the 11 studies included in the review. Nine studies of 1892 patients were included in meta-analysis. There was no significant difference in complete response of nausea and vomiting between a short or long course of dexamethasone (RR 0.98, 95% CI 0.89-1.07, P = .58) There were no differences in subgroup analysis. There was a lower risk of adverse events with a short course of dexamethasone as compared to a long course of dexamethasone (RR 0.80, 95% CI 0.64-0.99, P = .04). No heterogeneity was found in either analysis. Conclusion(s): There was no significant difference between a short or long course of dexamethasone in preventing nausea or vomiting, but a short course was associated with fewer adverse effects. Further research is required to determine the appropriate duration of dexamethasone for different chemotherapy protocols when used with modern anti-emetic regimens. | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Blackwell Publishing Ltd | en |
dc.title | Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting - a systematic review and meta-analysis. [Asia-Pacific Journal of Clinical Oncology] | en |
dc.type | Conference Abstract | en |
dc.type.studyortrial | Systematic review and/or meta-analysis | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url= | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/ajco.13263 | en |
local.date.conferencestart | 2019-11-12 | en |
dc.identifier.source | 634259125 | en |
dc.identifier.institution | (Raghunath) Monash Health, Notting Hill, VIC, Australia (Chandrasekara) Alfred Health, Melbourne, VIC, Australia (Anthony) RoyalMelbourne Hospital, Melbourne, VIC, Australia (Markman) Monash University, Melbourne, VIC, Australia | en |
dc.description.address | A. Raghunath, Monash Health, Notting Hill, VIC, Australia | en |
dc.description.publicationstatus | CONFERENCE ABSTRACT | en |
local.date.conferenceend | 2019-11-14 | en |
dc.rights.statement | Copyright 2021 Elsevier B.V., All rights reserved. | en |
dc.identifier.affiliationext | (Chandrasekara) Alfred Health, Melbourne, VIC, Australia | - |
dc.identifier.affiliationext | (Anthony) Royal Melbourne Hospital, Melbourne, VIC, Australia | - |
dc.identifier.affiliationext | (Markman) Monash University, Melbourne, VIC, Australia | - |
dc.identifier.affiliationmh | (Raghunath) Monash Health, Notting Hill, VIC, Australia | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Conference Abstract | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Monash Doctors Workforce | - |
Appears in Collections: | Conferences |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.